{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "26110817", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "26"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "09"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2015", "Month": "06", "Day": "25"}], "ELocationID": ["e0131412", "10.1371/journal.pone.0131412"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "6", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan.", "Pagination": {"StartPage": "e0131412", "MedlinePgn": "e0131412"}, "Abstract": {"AbstractText": ["This is the first report of the detection of two new anti-influenza drugs, peramivir (PER) and laninamivir (LAN), in Japanese sewage effluent and river waters. Over about 1 year from October 2013 to July 2014, including the influenza prevalence season in January and February 2014, we monitored for five anti-influenza drugs-oseltamivir (OS), oseltamivir carboxylate (OC), zanamivir (ZAN), PER, and LAN-in river waters and in sewage effluent flowing into urban rivers of the Yodo River system in Japan. The dynamic profiles of these anti-influenza drugs were synchronized well with that of the numbers of influenza patients treated with the drugs. The highest levels in sewage effluents and river waters were, respectively, 82 and 41 ng/L (OS), 347 and 125 ng/L (OC), 110 and 35 ng/L (ZAN), 64 and 11 ng/L (PER), and 21 and 9 ng/L (LAN). However, application of ozone treatment before discharge from sewage treatment plants was effective in reducing the levels of these anti-influenza drugs in effluent. The effectiveness of the ozone treatment and the drug dependent difference in susceptibility against ozone were further evidenced by ozonation of a STP effluent in a batch reactor. These findings should help to promote further environmental risk assessment of the generation of drug-resistant influenza viruses in aquatic environments."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Azuma", "ForeName": "Takashi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Ishiuchi", "ForeName": "Hirotaka", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Inoyama", "ForeName": "Tomomi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Teranishi", "ForeName": "Yusuke", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Yamaoka", "ForeName": "Misato", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Sato", "ForeName": "Takaji", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Environmental Quality Management, Kyoto University, Otsu, Shiga, Japan."}], "LastName": "Yamashita", "ForeName": "Naoyuki", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Environmental Quality Management, Kyoto University, Otsu, Shiga, Japan."}], "LastName": "Tanaka", "ForeName": "Hiroaki", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Osaka University of Pharmaceutical Sciences, Takatsuki, Osaka, Japan."}], "LastName": "Mino", "ForeName": "Yoshiki", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acids, Carbocyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclopentanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Guanidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrans"}, {"RegistryNumber": "0", "NameOfSubstance": "Sewage"}, {"RegistryNumber": "0", "NameOfSubstance": "Sialic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Water Pollutants, Chemical"}, {"RegistryNumber": "20O93L6F9H", "NameOfSubstance": "Oseltamivir"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "B408IW3GL5", "NameOfSubstance": "laninamivir"}, {"RegistryNumber": "K6106LV5Q8", "NameOfSubstance": "oseltamivir carboxylate"}, {"RegistryNumber": "L6O3XI777I", "NameOfSubstance": "Zanamivir"}, {"RegistryNumber": "QW7Y7ZR15U", "NameOfSubstance": "peramivir"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acids, Carbocyclic"}, {"QualifierName": ["analysis"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cities"}, {"QualifierName": ["analysis"], "DescriptorName": "Cyclopentanes"}, {"QualifierName": ["analysis"], "DescriptorName": "Drug Residues"}, {"QualifierName": ["methods"], "DescriptorName": "Environmental Monitoring"}, {"QualifierName": ["analysis"], "DescriptorName": "Guanidines"}, {"QualifierName": [], "DescriptorName": "Japan"}, {"QualifierName": [], "DescriptorName": "Limit of Detection"}, {"QualifierName": ["analogs & derivatives", "analysis"], "DescriptorName": "Oseltamivir"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Pyrans"}, {"QualifierName": [], "DescriptorName": "Risk Assessment"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rivers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sewage"}, {"QualifierName": [], "DescriptorName": "Sialic Acids"}, {"QualifierName": ["analysis"], "DescriptorName": "Water Pollutants, Chemical"}, {"QualifierName": [], "DescriptorName": "Water Purification"}, {"QualifierName": ["analogs & derivatives", "analysis"], "DescriptorName": "Zanamivir"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "S\u00f6derstr\u00f6m H, J\u00e4rhult JD, Olsen B, Lindberg RH, Tanaka H, Fick J (2009) Detection of the antiviral drug Oseltamivir in aquatic environments. PLoS ONE 4: e6064 10.1371/journal.pone.0006064", "ArticleIdList": ["10.1371/journal.pone.0006064", "PMC2699036", "19557131"]}, {"Citation": "Ghosh GC, Nakada N, Yamashita N, Tanaka H (2010) Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ Health Perspect 118: 103\u2013107. 10.1289/ehp.0900930", "ArticleIdList": ["10.1289/ehp.0900930", "PMC2831951", "20056566"]}, {"Citation": "Accinelli C, Caracciolo AB, Grenni P (2007) Degradation of the antiviral drug oseltamivir carboxylate in surface water samples. Int J Environ Anal Chem 87: 579\u2013587."}, {"Citation": "Sacc\u00e0 ML, Accinelli C, Fick J, Lindberg R, Olsen B (2009) Environmental fate of the antiviral drug Tamiflu in two aquatic ecosystems. Chemosphere 75: 28\u201333. 10.1016/j.chemosphere.2008.11.060", "ArticleIdList": ["10.1016/j.chemosphere.2008.11.060", "19124147"]}, {"Citation": "Prasse C, Schl\u00fcsener MP, Schulz R, Ternes TA (2010) Antiviral drugs in wastewater and surface waters: A new pharmaceutical class of environmental relevance? Environ Sci Technol 44: 1728\u20131735. 10.1021/es903216p", "ArticleIdList": ["10.1021/es903216p", "20108960"]}, {"Citation": "Azuma T, Nakada N, Yamashita N, Tanaka H (2012) Synchronous dynamics of observed and predicted values of anti-influenza drugs in environmental waters during a seasonal influenza outbreak. Environ Sci Technol 46: 12873\u201312881. 10.1021/es303203c", "ArticleIdList": ["10.1021/es303203c", "23106220"]}, {"Citation": "Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenstr\u00f6m J, Wallensten A, et al. (2007) Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: Implications for development of resistance by influenza A virus. PLoS ONE 2: e986", "ArticleIdList": ["PMC1991587", "17912363"]}, {"Citation": "J\u00e4rhult JD, Muradrasoli S, Wahlgren J, S\u00f6derstr\u00f6m H, Orozovic G, Gunnarsson G, et al. (2011) Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards. PLoS ONE 6: e24742 10.1371/journal.pone.0024742", "ArticleIdList": ["10.1371/journal.pone.0024742", "PMC3171471", "21931841"]}, {"Citation": "Achenbach JE, Bowen RA (2013) Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in mallard ducks. Antimicrob Agents Chemother 57: 2171\u20132181. 10.1128/AAC.02126-12", "ArticleIdList": ["10.1128/AAC.02126-12", "PMC3632944", "23459475"]}, {"Citation": "Takanami R, Ozaki H, Giri RR, Taniguchi S, Hayashi S (2012) Antiviral drugs zanamivir and oseltamivir found in wastewater and surface water in Osaka, J Water Environ Technol 10: 57\u201368."}, {"Citation": "Peng X, Wang C, Zhang K, Wang Z, Huang Q, Yu Y, et al. (2014) Profile and behavior of antiviral drugs in aquatic environments of the Pearl River Delta, China. Sci Total Environ 466\u2013467: 755\u2013761. 10.1016/j.scitotenv.2013.07.062", "ArticleIdList": ["10.1016/j.scitotenv.2013.07.062", "23973541"]}, {"Citation": "Bartels P, von T\u00fcmpling W Jr (2008) The environmental fate of the antiviral drug oseltamivir carboxylate in different waters. Sci Total Environ 405: 215\u2013225. 10.1016/j.scitotenv.2008.06.032", "ArticleIdList": ["10.1016/j.scitotenv.2008.06.032", "18675443"]}, {"Citation": "Accinelli C, Sacc\u00e0 Maria L, Fick J, Mencarelli M, Lindberg R, Olsen B (2010) Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments. Chemosphere 79: 891\u2013897. 10.1016/j.chemosphere.2010.02.022", "ArticleIdList": ["10.1016/j.chemosphere.2010.02.022", "20226496"]}, {"Citation": "Gon\u00e7alves C, P\u00e9rez S, Osorio V, Petrovic M, Alpendurada MF, Barcel\u00f3 D (2011) Photofate of oseltamivir (Tamiflu) and oseltamivir carboxylate under natural and simulated solar irradiation: Kinetics, identification of the transformation products, and environmental occurrence. Environ Sci Technol 45: 4307\u20134314. 10.1021/es1032629", "ArticleIdList": ["10.1021/es1032629", "21495632"]}, {"Citation": "Accinelli C, Sacc\u00e0 ML, Mencarelli M, Vicari A (2012) Application of bioplastic moving bed biofilm carriers for the removal of synthetic pollutants from wastewater. Biores Technol 120: 180\u2013186.", "ArticleIdList": ["22797083"]}, {"Citation": "Azuma T, Nakada N, Yamashita N, Tanaka H (2013) Mass balance of anti-influenza drugs discharged into the Yodo River system, Japan, under an influenza outbreak. Chemosphere 93: 1672\u20131677. 10.1016/j.chemosphere.2013.05.025", "ArticleIdList": ["10.1016/j.chemosphere.2013.05.025", "23871592"]}, {"Citation": "Zonja B, Gon\u00e7alves C, P\u00e9rez S, Delgado A, Petrovic M, Alpendurada MF, et al. (2014) Evaluation of the phototransformation of the antiviral zanamivir in surface waters through identification of transformation products. J Hazard Mater 265: 296\u2013304. 10.1016/j.jhazmat.2013.10.008", "ArticleIdList": ["10.1016/j.jhazmat.2013.10.008", "24211180"]}, {"Citation": "Kohno S, Kida H, Mizuguchi M, Shimada J (2010) Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Age Chemother 54: 4568\u20134574.", "ArticleIdList": ["PMC2976170", "20713668"]}, {"Citation": "Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, et al. (2012) Clinical effectiveness of neuraminidase inhibitors\u2014oseltamivir, zanamivir, laninamivir, and peramivir\u2014for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010\u20132011 influenza season in Japan. J Infect Chemother 18: 858\u2013864. 10.1007/s10156-012-0428-1", "ArticleIdList": ["10.1007/s10156-012-0428-1", "22644080"]}, {"Citation": "Tanaka A, Seki M, Kosai K, Kawano S (2010) Peramivir (in Japanese). Jpn J Clin Exp Med 87: 1702\u20131706."}, {"Citation": "Watanabe A (2010) Laninamivir (CS-8958, Inavir) (in Japanese). Jpn J Clin Exp Med 87: 1707\u20131712."}, {"Citation": "Ishizuka H, Yoshiba S, Okabe H, Yoshihara K (2010) Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS-8958, in Healthy Male Volunteers. J Clin Pharmacol 50: 1319\u20131329. 10.1177/0091270009356297", "ArticleIdList": ["10.1177/0091270009356297", "20145259"]}, {"Citation": "Hoffmann-La Roche Inc. Nutley NJ (2005) Roche research report; Pediatric advisory committee executive summary for Tamiflu. 1\u201322."}, {"Citation": "Kim I, Tanaka H (2010) Use of ozone-based processes for the removal of pharmaceuticals detected in a wastewater treatment plant. Water Environ Res 82: 294\u2013301.", "ArticleIdList": ["20432647"]}, {"Citation": "Kim I, Tanaka H (2011) Energy consumption for PPCPs removal by O3 and O3/UV. Ozone Sci Eng 33: 150\u2013157."}, {"Citation": "Ternes TA, St\u00fcber J, Herrmann N, McDowell D, Ried A, Kampmann M, et al. (2003) Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Res 37: 1976\u20131982.", "ArticleIdList": ["12697241"]}, {"Citation": "Rosal R, Rodr\u00edguez A, Perdig\u00f3n-Mel\u00f3n JA, Petre A, Garc\u00eda-Calvo E, G\u00f3mez MJ, et al. (2010) Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 44: 578\u2013588. 10.1016/j.watres.2009.07.004", "ArticleIdList": ["10.1016/j.watres.2009.07.004", "19628245"]}, {"Citation": "George H, Joseph M, Penelope W (1999) Clinical pharmacokinetics of the prodrug Oseltamivir and its active metabolite Ro 64\u20130802. Clin Pharmacokinet 37: 471\u2013484.", "ArticleIdList": ["10628898"]}, {"Citation": "Lindsey MR, Cass CE, Alan B (1999) Pharmacokinetics of Zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers. Clin Pharmacokinet Suppl.36: 1\u201311.", "ArticleIdList": ["10429835"]}, {"Citation": "Lindeg\u00e5rdh N, Hien TT, Farrar J, Singhasivanon P, White NJ, Day NPJ (2006) A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu\u00ae. J Pharm Biomed Anal 42: 430\u2013433.", "ArticleIdList": ["16750606"]}, {"Citation": "F. Hoffmann-La Roche Ltd. (2008) Product monograph Tamiflu. Mississauga, Ontario, Canada."}, {"Citation": "Straub JO (2009) An environmental risk assessment for oseltamivir (Tamiflu\u00ae) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions. Ecotoxicol Environ Saf 72: 1625\u20131634. 10.1016/j.ecoenv.2008.09.011", "ArticleIdList": ["10.1016/j.ecoenv.2008.09.011", "19560203"]}, {"Citation": "Chemical Abstracts Service SciFinder. American Chemical Society. SciFinder online database (Subscription database)."}, {"Citation": "Widmer N, Meylan P, Ivanyuk A, Aouri M, Decosterd LA, Decosterd LA, Buclin T (2010) Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics. Clin Pharmacokinet 49: 741\u2013765. 10.2165/11534730-000000000-00000", "ArticleIdList": ["10.2165/11534730-000000000-00000", "20923248"]}, {"Citation": "GlaxoSmithKline (2006) Zanamivir. Safety data sheet Ver 13: 1\u20138."}, {"Citation": "Shionogi & Co. Ltd. (2010) Rapiacta\u00ae for intravenous drip infusion: package insert (In Japanese.). Shionogi & Co., Ltd, Osaka, Japan."}, {"Citation": "\nSPARC On-Line Calculator v4.6 (2011) University of Georgia, Atlanta, GA, USA:  Available from <http://sparc.chem.uga.edu/sparc/>. (accessed April 27, 2015)"}, {"Citation": "Osaka Prefectural Government (Japan) (2012) River development project of Kanzaki River in Yodo River system (in Japanese). Osaka: 1\u201350."}, {"Citation": "Kumar V, Nakada N, Yasojima M, Yamashita N, Johnson AC, Tanaka H (2009) Rapid determination of free and conjugated estrogen in different water matrices by liquid chromatography-tandem mass spectrometry. Chemosphere 77: 1440\u20131446. 10.1016/j.chemosphere.2009.08.052", "ArticleIdList": ["10.1016/j.chemosphere.2009.08.052", "19772979"]}, {"Citation": "Azuma T, Nakada N, Yamashita N, Tanaka H (2014) Optimisation of the analysis of anti-influenza drugs in wastewater and surface water. International Journal of Environ Anal Chem 94: 853\u2013862."}, {"Citation": "Leknes H, Sturtzel IE, Dye C (2012) Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic. Sci Total Environ 414: 632\u2013638. 10.1016/j.scitotenv.2011.11.004", "ArticleIdList": ["10.1016/j.scitotenv.2011.11.004", "22127154"]}, {"Citation": "Okuda T, Yamashita N, Tanaka H, Matsukawa H, Tanabe K (2009) Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants. Environ Int 35: 815\u2013820. 10.1016/j.envint.2009.01.006", "ArticleIdList": ["10.1016/j.envint.2009.01.006", "19201472"]}, {"Citation": "Infectious Disease Surveillance Center (Japan) Infectious Diseases Weekly Report (IDWR) (in Japanase). Available from <http://idsc.nih.go.jp/index-j.html>. (accessed April 27, 2015)"}, {"Citation": "Osaka Prefecture Infectious Disease Surveillance Center (Japan) Infectious Diseases Weekly Report (in Japanase). Available from <http://www.iph.pref.osaka.jp/index.html>. (accessed April 27, 2015)"}, {"Citation": "Yoon S, Tanaka H (2014) Optimum conditions for testing N-nitrosamine formation potential (FP) through ozonation in wastewater samples. J Ind and Eng Chem 20: 2914\u20132920."}, {"Citation": "Kim IH, Tanaka H, Iwasaki T, Takubo T, Morioka T, Kato Y (2008) Classification of the degradability of 30 pharmaceuticals in water with ozone, UV and H2O2 . Water Sci Technol 57: 195\u2013200. 10.2166/wst.2008.808", "ArticleIdList": ["10.2166/wst.2008.808", "18235171"]}, {"Citation": "Antoniou MG, Hey G, Rodr\u00edguez VS, Spiliotopoulou A, Fick J, Tysklind M (2013) Required ozone doses for removing pharmaceuticals from wastewater effluents. Sci Total Environ 456\u2013457: 42\u201349. 10.1016/j.scitotenv.2013.03.072", "ArticleIdList": ["10.1016/j.scitotenv.2013.03.072", "23584032"]}, {"Citation": "Singer AC, Nunn MA, Gould EA, Johnson AC (2007) Potential risks associated with the proposed widespread use of Tamiflu. Environ Health Perspect 115: 102\u2013106.", "ArticleIdList": ["PMC1797841", "17366827"]}, {"Citation": "Renner R (2007) Tamiflu survives sewage treatment. Environ Sci Technol 41: 7591", "ArticleIdList": ["18075061"]}, {"Citation": "Li W, Escarpe PA, Eisenberg EJ, Cundy KC, Sweet C, Jakeman KJ, et al. (1998) Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother 42: 647\u2013653.", "ArticleIdList": ["PMC105512", "9517946"]}, {"Citation": "Williams MA, Kim CU, Lew W, Zhang L, Swaminathan S, Bischofberger N, et al. (1997) GS 4104: A highly potent orally bioavailable influenza neuraminidase inhibitor. Antiviral Res 34: 86."}, {"Citation": "Hutchinson TH, Beesley A, Frickers PE, Readman JW, Shaw JP, Straub JO (2009) Extending the environmental risk assessment for oseltamivir (Tamiflu\u00ae) under pandemic use conditions to the coastal marine compartment. Environ Int 35: 931\u2013936. 10.1016/j.envint.2009.04.001", "ArticleIdList": ["10.1016/j.envint.2009.04.001", "19395032"]}, {"Citation": "Chen WY, Lin CJ, Liao CM (2014) Assessing exposure risks for aquatic organisms posed by Tamiflu use under seasonal influenza and pandemic conditions. Environ Pollut 184: 377\u2013384. 10.1016/j.envpol.2013.09.019", "ArticleIdList": ["10.1016/j.envpol.2013.09.019", "24095813"]}, {"Citation": "Hurt AC, Selleck P, Komadina N, Shaw R, Brown L, Barr IG, (2007) Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res 73: 228\u2013231.", "ArticleIdList": ["17112602"]}, {"Citation": "Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, et al. (2008) Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol 41: 25\u201328.", "ArticleIdList": ["18055253"]}, {"Citation": "Centersfor Disease Controland Prevention (USA) (2009) Update: Drug susceptibility of swine-origin influenza A(H1N1) Viruses, April 2009. Morbidity and Mortality Weekly Report (MMWR) 58: 421\u2013452.", "ArticleIdList": ["19407738"]}, {"Citation": "Okomo-Adhiambo M, Sleeman K, Ballenger K, Nguyen HT, Mishin VP, Sheu TG, et al. (2010) Neuraminidase inhibitor susceptibility testing in human influenza viruses: A laboratory surveillance perspective. Viruses 2: 2269\u20132289. 10.3390/v2102269", "ArticleIdList": ["10.3390/v2102269", "PMC3185571", "21994620"]}, {"Citation": "Correia V, de Andrade HR, Santos LA, Lackenby A, Zambon M (2010) Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons. Antiviral Res 86: 128\u2013136. 10.1016/j.antiviral.2010.01.002", "ArticleIdList": ["10.1016/j.antiviral.2010.01.002", "20083142"]}, {"Citation": "Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021\u20131025. 10.1038/nature08260", "ArticleIdList": ["10.1038/nature08260", "PMC2748827", "19672242"]}, {"Citation": "Yamashita M, Tomozawa T, Kakuta M, Tokumitsu A, Nasu H, Kubo S (2009) CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob Agents Chemother 53: 186\u2013192. 10.1128/AAC.00333-08", "ArticleIdList": ["10.1128/AAC.00333-08", "PMC2612152", "18955520"]}, {"Citation": "Ellis JB (2010) Antiviral pandemic risk assessment for urban receiving waters. Water Sci Technol 61: 879\u2013884. 10.2166/wst.2010.002", "ArticleIdList": ["10.2166/wst.2010.002", "20182065"]}, {"Citation": "Singer AC, Colizza V, Schmitt H, Andrews J, Balcan D, Huang WE, et al. (2011) Assessing the ecotoxicologic hazards of a pandemic influenza medical response. Environ Health Perspect 119: 1084\u20131090. 10.1289/ehp.1002757", "ArticleIdList": ["10.1289/ehp.1002757", "PMC3237342", "21367688"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "1", "Day": "6"}, {"Year": "2015", "Month": "6", "Day": "2"}, {"Year": "2015", "Month": "6", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "6", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "6", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["26110817", "PMC4482326", "10.1371/journal.pone.0131412", "PONE-D-14-57345"]}}], "PubmedBookArticle": []}